Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
GI Dynamics, Inc., a Lexington, Mass.-based company known for its EndoBarrier Therapy, which it claims can reduce blood-sugar levels and offer weight-loss results in Type 2 Diabetes patients, has raised $34,755,000 in equity and CDIs, according to a regulatory filing it made with the SEC on July 22. The company still seeks $17,745,000, which it expects in August 2013, following shareholder approval, according to the company’s press contact, Dan Budwick. The company recently announced this oversubscribed private placement with additional investments from a number of existing investors and welcoming several new institutional shareholders to the register.
Help employers find you! Check out all the jobs and post your resume.
